United States · FDA National Drug Code directory
Pregabalin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72205-014_d1428cf2-1243-43cb-8b54-f46024dbca29
- Product NDC
- 72205-014
- Form
- CAPSULE
- Composition / generic term
- Pregabalin
- Labeler
- Novadoz Pharmaceuticals LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190719
- Source listing expiry
- 20261231
Source-listed ingredients
- PREGABALIN — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 BLISTER PACK in 1 CARTON (72205-014-06) / 10 CAPSULE in 1 BLISTER PACK (72205-014-11) · 72205-014-06
- 90 CAPSULE in 1 BOTTLE (72205-014-90) · 72205-014-90
- 1000 CAPSULE in 1 BOTTLE (72205-014-99) · 72205-014-99
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →